Drug-drug Interaction Study of CHF5993 With Cimetidine The purpose of this study is to evaluate the pharmacokinetic interaction when CHF5993 (pressurized metered-dose inhaler (pMDI) is administered with Cimetidine (probe inhibitor of the organ...

• Country None
• organs None
• Specialty None

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses (MAD) of GLPG0555 given to healthy subjects for 13 days compared to placebo, and to eva...

• Country Belgium
• organs None
• Specialty None

GLPG0259 Solid Formulation Bioavailability and Food Effect The purpose of the study is to compare the pharmacokinetics of GLPG0259 as a solid dosage formulation (with and without food)and an oral solution, and to assess its safety and tolerability...

• Country None
• organs None
• Specialty None

First-in-Human Single Ascending and Multiple Dose of GLPG0555 The purpose of the study is to evaluate the safety and tolerability of single ascending (SAD) and multiple (MD) oral dose of GLPG0555 compared to placebo. Also, pharmacokinetics (PK) and ...

• Country None
• organs None
• Specialty None

First-in-Human Exploratory Single Ascending Dose of GLPG0974 The purpose of this exploratory first-in-human study is to evaluate the amount of GLPG0974 present in the blood (pharmacokinetics) after single oral doses of GLPG0974 given to healthy subj...

• Country None
• organs None
• Specialty None